Arcoma AB (ARCOMA) — Capital Reinvestment Ratio
Latest as of June 2025:
0.14x
Arcoma AB (ARCOMA) has a Capital Reinvestment Ratio of 0.14x as of June 2025, meaning it reinvests 0% of its operating cash flow (Skr7.85 Million) in capital expenditures (Skr1.08 Million). See ARCOMA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.14x
Capex / Operating Cash Flow
Operating Cash Flow
Skr7.85 Million
SEK
Capital Expenditures
Skr1.08 Million
SEK
Data as of
Jun 2025
Most recent filing
Arcoma AB Capital Reinvestment Ratio (2018–2024)
This chart tracks Arcoma AB's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Arcoma AB (2018–2024)
Year-by-year Capital Reinvestment Ratio for Arcoma AB from 2018 to 2024. For live market cap and broader valuation context, see ARCOMA market cap.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.36x | Skr18.84 Million | Skr6.78 Million | ▲ +170.0% |
| 2023 | 0.13x | Skr19.16 Million | Skr2.55 Million | ▼ -92.2% |
| 2020 | 1.71x | Skr6.85 Million | Skr11.70 Million | ▲ +70.5% |
| 2019 | 1.00x | Skr11.10 Million | Skr11.13 Million | ▼ -95.1% |
| 2018 | 20.36x | Skr45.00K | Skr916.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow